Actinomycetoma with systemic features: A warning sign for immunosuppression?

PLoS Negl Trop Dis. 2020 Dec 3;14(12):e0008865. doi: 10.1371/journal.pntd.0008865. eCollection 2020 Dec.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Immunocompromised Host*
  • Lymphoma / complications*
  • Lymphoma / drug therapy
  • Male
  • Mycetoma / complications*
  • Mycetoma / drug therapy
  • Mycetoma / microbiology
  • Nocardia / isolation & purification
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination

Grants and funding

The author(s) received no specific funding for this work.